CT angiography in an acute stroke protocol: Correlation between occlusion site and outcome of intravenous thrombolysis

Interventional Neuroradiology

Volumn 19, Issue 1, 2013, Pages 87-96

  Porelli, Sayuri ^a   Leonardi, M ^b   Stafa, A ^c   Barbara, C ^c   Procaccianti, G ^c   Simonetti, L ^c  

^a IRCCS ISTITUTO DELLE SCIENZE NEUROLOGICHE DI BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c MAGGIORE HOSPITAL   (Italy)

Author keywords

CT angiography; Head and neck; Occlusion site; Stroke; Thrombolysis

Indexed keywords

ALTEPLASE;

AGED; ARTICLE; ASPECT SCORE; BLEEDING; BLOOD CLOT LYSIS; CEREBROVASCULAR ACCIDENT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; RANKIN SCALE; SCORING SYSTEM; TREATMENT OUTCOME;

EID: 84876307330     PISSN: 15910199     EISSN: None     Source Type: Journal    
DOI: 10.1177/159101991301900114     Document Type: Article

References (37)

1. Mori E, Yoneda Y, Tabuchi M, et al. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 1992; 42: 976-982.
2. Haley EC Jr, Brott TG, Sheppard GL, et al. Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. The TPA Bridging Study Group. Stroke. 1993; 24: 1000-1004. (Pubitemid 23201457)
3. The National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group. Tissue Plasminogen Activator for acute ichemic stroke. N Engl J Med. 1995; 333: 1581-1587.
4. Hacke W, Kaste M, Fieschi C, et al. The European Cooperative Acute Stroke Study (ECASS) Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. JAMA. 1995; 274 (13): 1017-1025.
5. The NINDS t-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke. 1997; 28 (11): 2109-2118.
6. Brott TG, Haley EC Jr, Levy DE, et al. Urgent therapy for stroke. I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke. 1992; 23: 632-40.
7. Haley EC Jr, Levy DE, Brott TG, et al. Urgent therapy for stroke. II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset. Stroke. 1992; 23: 641-645.
8. Marler JR, Tilley BC, Lu M, et al. Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology. 2000; 55 (11): 1649-1655.
9. Hacke W, Donnan G, Fieschi C, et al. ATLANTIS Trials Investigators; ECASS Trials Investigators; NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004; 363 (9411): 768-774.
10. The NINDS t-PA Stroke Study Group. Generalized efficacy of t-PA for acute stroke: subgroup analysis of the NINDS t-PA Stroke Trial. Stroke. 1997; 28: 2119-2125.
11. Kasim KA, Brizzi M, Petersson J, et al. Combined clinical and radiological prognostic model in acute ischemic stroke. Acta Neurol Belg. 2010; 110 (3): 239-245.
12. Saňák D, Herzig R, Zapletalová J, et al. Predictors of good clinical outcome in acute stroke patients treated with intravenous thrombolysis. Acta Neurol Scand. 2011; 123 (5): 339-344.
13. von Kummer R, Allen KL, Holle R, et al. Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology. 1997; 205 (2): 327-333. (Pubitemid 27467308)
14. Trouillas P, Nighoghossian N, Derex L, et al. Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke: determination of etiological, topographic, and radiological outcome factors. Stroke. 1998; 29 (12): 2529-2540. (Pubitemid 28544003)
15. Del Zoppo GJ, Poeck K, Pessin MS, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol. 1992; 32: 78-86.
16. Linfante I, Llinas RH, Selim M, et al. Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusions after intravenous tissue plasminogen activator. Stroke. 2002; 33 (8): 2066-2071. (Pubitemid 34840069)
17. Derex L, Nighoghossian N, Hermier M, et al. Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator. J Neurol Sci. 2004; 225 (1-2): 3-9. (Pubitemid 39311703)
18. Derex L, Hermier M, Adeleine P, et al. Influence of the site of arterial occlusion on multiple baseline hemodynamic MRI parameters and post-thrombolytic recanalization in acute stroke. Neuroradiology. 2004; 46 (11): 883-887. (Pubitemid 40057969)
19. De Silva DA, Brekenfeld C, Ebinger M, et al. Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) Investigators. The benefits of intravenous thrombolysis relate to the site of baseline arterial occlusion in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET). Stroke. 2010; 41 (2): 295-299.
20. Sims JR, Rordorf G, Smith EE, et al. Arterial occlusion revealed by CT Angiography predicts NIH Stroke Score and acute outcomes after IV tPA treatment. Am J Neuroradiol. 2005; 26: 246-251. (Pubitemid 43073300)
21. Saqqur M, Uchino K, Demchuk AM, et al. CLOT-BUST Investigators. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke. 2007; 38 (3): 948-954. (Pubitemid 46568457)
22. Tan IY, Demchuk AM, Hopyan J, et al. CT angiography clot burden score and collateral score: correlation with clinical and radiologic outcomes in acute middle cerebral artery infarct. Am J Neuroradiol. 2009; 30 (3): 525-531.
23. Puetz V, Dzialowski I, Hill MD, et al. Calgary CTA Study Group. Intracranial thrombus extent predicts clinical outcome, final infarct size and hemorrhagic transformation in ischemic stroke: the clot burden score. Int J Stroke. 2008; 3 (4): 230-236.
24. The European Stroke Organization (ESO) Executive Committee and the ESO Writing Committee. Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack. 2008. http://www.eso-stroke.org.
25. Barber PA, Demchuk AM, Zhang J, et al. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. Lancet. 2000; 355: 1670-1674. (Pubitemid 30248478)
26. Van Swieten JC, Koudstaal PJ, Visser MC, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988; 19: 604-607.
27. De Haan R, Limburg M, Bossuyt P, et al. The clinical meaning of Rankin "Handicap" grades after stroke. Stroke. 1995; 26: 2027-2030.
28. Wahlgren N, Ahmed N, Dávalos A, et al. SITS-MOST investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet. 2007; 369 (9558): 275-282. (Pubitemid 46138121)
29. Pessin MS, Del Zoppo GJ, Estol CJ. Thrombolytic agents in the treatment of stroke. Clin Neuropharmacol. 1990; 13 (4): 271-289. (Pubitemid 20230322)
30. Wolpert SM, Bruckmann H, Greenlee R, et al. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group. Am J Neuroradiol. 1993; 14 (1): 3-13. (Pubitemid 23055914)
31. Fiorelli M, Bastianello S, von Kummer R, et al. Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke. 1999; 30 (11): 2280-2284. (Pubitemid 29517722)
32. Berger C, Fiorelli M, Steiner T, et al. Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? Stroke. 2001; 32 (6): 1330-1335. (Pubitemid 32530418)
33. Trouillas P, von Kummer R. Classification and pathogenesis of cerebral hemorrhages after thrombolysis in ischemic stroke. Stroke. 2006; 37 (2): 556-561. (Pubitemid 43732026)
34. Overgaard K. Thrombolytic therapy in experimental embolic stroke. Cerebrovasc Brain Metab Rev. 1994; 6 (3): 257-286.
35. Barbara C, Rossi D, Procaccianti G, et al. Quantitative determination in the CT diagnosis of ischaemic and heamorragic stroke. The Neuroradiology Journal. 2007; 20 (Suppl 1): 110.
36. Simonetti L, Barbara C, Procaccianti G, et al. Is MR really essential in the diagnosis of acute carotid and vertebral dissections? The Neuroradiology Journal 2007; 20 (Suppl 1): 127-128.
37. Barbara C, Stafa A, Procaccianti G, et al. CT-Angiography and thrombolysis in acute ischemic stroke. Correlations between occlusion's level and nihss improvement. Our experience based on 127 patients. The Neuroradiology Journal 2009; 22: 771.